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Considerable  indirect  data  suggest  that  viruses  may be  of etiologic impor- 
tance  in  systemic  lupus  erythematosus  (SLE).  Electron  microscopic  studies 
have  demonstrated  the  presence  of  tubulo-reticular  structures  resembling 
paramyxoviruses  in  the  cytoplasm  of  many  different  cell  types  from  SLE 
patients,  including lymphocytes (1-4),  although  their  viral  nature  or deriva- 
tion  remains  controversial.  Other  studies  have  attempted  to  define  by sero- 
logical means  the association  of a  particular  virus or a  group of viruses with 
this disease  (5-8). Antibody levels were found to be elevated  to a  number of 
viruses, but it has been difficult to separate specific antibody increase from the 
polyclonal  elevation  of immunoglobulins  characteristic  of  these  patients  (7). 
Using a  new  approach  to  the  question  of viruses  in  SLE,  we have  examined 
cell-mediated  immunity  to  several  viruses  using  the  direct  leukocyte  migra- 
tion inhibition  assay. Because most studies have shown antibody elevation to 
measles,  rubella,  and parainfluenza  type  1,  these  were  chosen as  antigens.  A 
specific depression  of direct  leukocyte migration  inhibition  was found  to  the 
measles antigen in patients with SLE as compared with controls,  while normal 
inhibition  to  migration  occurred  with  rubella  and  parainfluenza  type  1  in 
these patients. 
Materials and Methods 
Patients.--17 unselected patients  from the outpatient clinic of The Rockefeller University 
Hospital  were studied.  Except for one patient  (Mal) with  discoid lupus,  all met the pre- 
liminary criteria  of the American Rheumatism  Association (9) for diagnosis of SLE. A sum- 
mary of the pertinent  clinical data is included in Table I. The controls were healthy unre- 
lated normals. 
Direct Leukocyte Migration.--The  method  of direct  migration  inhibition  of peripheral 
blood leukocytes  (DMI) as originally described by Bendixen (10) and modified as described 
earlier (11) was used in all experiments. 
Antigens.--All antigens were obtained from Flow Laboratories,  Inc., Rockville, Md. The 
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measles virus  (lot nos. M944034  and M944036,  complement fixation (CF)  titer 1:32)  was 
the Edmonston 84F strain, final passage being in a  primary African green monkey kidney 
culture with BME (Earle's salts) and 2% fetal bovine serum. The activated antigen prepara- 
tion was prepared by freeze-thawing of virus infected cells, followed by sonication of the dis- 
rupted cells,  and mild centrifugation to remove large cellular debris. The supernatant fluid 
containing measles antigens was used in the test system. Type 1 parainfluenza antigen (lot 
no. E921036  CF titer 1:32)  was from the Sendai strain and was grown in embryonated hens' 
eggs (allantoic fluid). The Rubella antigen (CF titer 1 : 16) was prepared as an alkaline extract 
of rubella-(Gilchrist) infected BHK-21  (C/13) cell cultures and reconstituted in the medium 
described above  (Flow Laboratories, Inc.). Lot nos. L960133  and  C961207 were used. All 
antigen preparations, which contained no preservatives, were stored at --60°C. Appropriate 
dilutions were made immediately before use. Control antigens (i.e., supernates from the ap- 
propriate tissue culture lines but without virus, also provided by Flow Laboratories, Inc., 
were added to the medium in parallel with test antigens, to create the control fans. 
Cytotoxidty Assay.--Antibodies to lymphocytes were determined in the serum of each pa- 
tient by a  two step microcytotoxicity assay as previously described (12). Maximum sensi- 
tivity was obtained by performing the assay at 15°C. Sera were tested against a  panel of 25 
normal and  SLE peripheral blood lymphocytes, as  well  as  with  autologous  lymphocytes 
in many cases. Strength of cytotoxic antibodies is expressed as strength index (the number 
of strongly positive assays in which more than 70%  of  lymphocytes were  killed,  divided 
by the total number of positive assays X  100). 
RESULTS 
The patients with SLE showed a  marked lack of responsiveness to measles 
antigen as compared with the normal controls (see Fig.  1). The mean migra- 
tion inhibition index to measles antigen at a 1 : 10 dilution was -- 19.3 % (SE ± 
4.9%)  for  the  patients,  against  --47.6%  (SE ±  3.3%)  for  controls  (P < 
0.001  by Student's t test). At 1:100 dilution of the measles antigen, the same 
difference held:  --4.6%  (SE 4-3.2)  for  the  patients  and  --26.2%  (SE 4- 
3.2 %)  for the  controls  (P <  0.001  by Student's t  test).  However, SLE and 
normal leukocytes did not differ in their response to either rubella or to para- 
influenza type 1 antigens  (P >  0.6 for rubella 1:40,  and P  >  0.95 for para- 
influenza 1 : 10 and P  >  0.1 at 1 : 100; see Fig. 1). 
The degree of unresponsiveness to measles antigen did not show any obvious 
correlation with any specific clinical feature of the disease (e.g., nephritis) nor 
did it correlate with the use of immunosuppressive therapy (see Table I). In 
addition,  the  patients  on  immunosuppressive  therapy showed  a  normal  in- 
hibitory response to the rubella and parainfluenza antigens. Only one patient 
(Hen) was unresponsive to all the antigens tested. 
Antibodies  to  lymphocytes  were  commonly present  (12/15  patients;  see 
Table I) when sera were examined against a panel of normal peripheral blood 
lymphocytes. 6 of 12 sera exhibited autologous lymphocytotoxicity, although 
this could only be demonstrated by performing the assay at 15°C.  Cytotoxic 
activity was, with one exception (Hen), not present at 37°C. It is interesting 
to speculate whether this patient's failure to respond to any of the antigens is 
secondary to the presence of this autocytotoxic antibody. e-- 
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FIG. I. A comparison of the migration inhibition values to viral antigens in patients with 
systemic lupus erythematosus and normal subjects. 
Seven patients  with  rheumatoid  arthritis  and  one patient  with  Sj6gren's 
syndrome were studied using the measles and the parainfluenza type I antigens. 
The patient  with  SjSgren's  syndrome showed  normal  responsiveness  to  the 
measles  antigen,  and  a  somewhat  depressed  response  to  the  parainfluenza 
antigen at a  1:100 dilution. Four of the patients, with long-standing rheuma- 
toid arthritis,  showed no response to  either antigen.  One patient responded 
in  a  normal fashion to both  antigens.  Two patients  responded with  low in- 
hibition (<30 %) to both antigens. 
DISCUSSION 
In these experiments, a specific failure of leukocytes from SLE patients to 
respond to measles antigen was detected in the direct migration inhibition test, 
whereas a normal inhibitory response was seen with these patients' leukocytes 
to both parainfluenza type 1 and rubella antigens. We are currently extending 
these tests to include mumps antigen, and preliminary evidence indicates that 
the reaction of SLE patients to this antigen is normal as well. 
Neither disease activity, as judged clinically and serologically, nor immuno- 
suppressive therapy showed an obvious Correlation with the degree of failure 
of migration inhibition to the measles antigen. Lymphocytotoxic antibodies do 
not seem to be responsible for this phenomenon, as there was no relationship 
between the presence of antibodies to lymphocytes as measured by the lympho- 
cytotoxic assay and the failure of migration inhibition to measles antigen. This 1022  UTERMOHLEN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Correlatio~ o/Migration Inhibition  to Measles Antigen  of SLE Leukocytes with Lymphocyto- 
toxic Antibodies, Clinical Parameters, and Therapy 
Autologous  Anti-  DNA  Therapy  Measles  Cytotoxi-  lymphocyto-  Clinical  , 
Patient  migration  city  toxicity  C'H60*  (% C~'~  ESR**  disease  Pred-  Azathi- 
inhibition index  strengthindex  (%killed)Cells  DNAbind_  activity  nisone  oprine 
ing) ¶ 
mg/d  mg/d 
His  417.2§  38  0  113  32  94  4  10  -- 
Mal  47.9  0  ND  200  30  28  --  --  -- 
Esp  44.2  70  0  127  41  30  4  20  -- 
Hen  -- 5.8  50  0  85  43  39  --  --  -- 
Wzx  -- 7.1  ND]I  ND  122  39  50  --  --  -- 
San  -- 8.7  8  60  99  22  42  --  15  -- 
Abb  -12.8  0  0  189  46  17  --  5  50 
McI  -- 13.6  80  90  141  35  55  4  I0  50 
See  -- 14.9  0  ND  100  14  2  --  15  75 
Nap  --15.8  ND  ND  175  23  ND  4  10  -- 
Won  --27.0  72  70  125  42  70  4  20  75 
Ite  --33.4  100  90  182  27  67  4  20  -- 
Hars  -- 39.1  6  0  138  44  12  --  --  -- 
Tit  --40.3  26  50  211  50  111  --  --  -- 
Car  --44.0  17  ND  140  57  44  --  15  -- 
Harv  --46.3  34  0  114  55  92  4  30  -- 
DiP  --49.0  67  90  104  30  25  4  --  -- 
* CH50, normal >  150. 
I: ESR, erythrocyte sedimentation rate. 
§ 4, °fo stimulation (control fans smaller than antigen fans). 
H  ND, not done. 
¶  Upper limit of normal DNA binding, 26%. 
lack  of  relationship  also  obtained  when  autologous  cytotoxic  reactions  alone 
were considered. 
Whether  noncytotoxic  antibodies  specific  for  measles  antigen,  perhaps 
analogous  to  those  shown  to  block  the  mixed  lymphocyte  reaction  in  SLE 
(14),  are  responsible  for  this  failure  of  inhibition  remains  a  possibility.  It 
has  been  shown  that  lymphocytes  from  SLE  patients  may  be  coated  with 
immunoglobulins  even  after  extensive  washing  (R.  Winchester  et  al.,  manu- 
script  in preparation).  However,  preliminary  experiments  in which  the  assay 
was  performed  with  leukocytes  from  normal  donors  in  the presence  of  lupus 
serum  (instead  of  fetal  calf  serum)  have  failed  to  reproduce  the  specific  un- 
responsiveness to measles antigen seen with lupus cells. 
The  specificity  of  the  failure  of  inhibition  of  migration  to  measles  antigen 
would  seem  to  argue  against  this being due  to  a  generalized defect of  cellular 
immunity  in  SLE  for  which  there  is  certain  evidence  (15).  However,  the 
possibility remains that reactivity to measles antigen in this test  system repre- UTERMOHLEN  ET AL.  BRIEF DEFINITIVE REPORT  1023 
sents a more sensitive index of such a defect than  reactivity to the other viral 
antigens. 
Leukocyte migration values seen in patients with SLE closely parallel those 
seen in patients with multiple sclerosis (MS) (11), but are different from those 
obtained with leukocytes from patients  with rheumatoid  arthritis.  The data 
thus  far obtained suggest  the possibility that  failure of response to measles 
antigen may be peculiar to both MS and SLE. In spite of the obvious clinical 
differences between SLE and MS,  there are points of basic mmilarity:  (a)  a 
viral etiology has been postulated for both;  (b)  the presence of similar virus- 
like or virus-related particles has been demonstrated, in the brain of patients 
with MS  (16), and in various tissues, including lymphocytes, in patients with 
SLE; (c) a  defect in cell-mediated immunity has been suggested in both (15, 
17).  Whether this unresponsiveness to measles antigen is related to a  general 
defect in cellular immunity, to a specific T-cell defect (e.g., absent or blocked 
viral receptors), to the presence of latent measles or closely related virus, or to 
an abnormal antibody response to measles antigen, is unclear at this time. 
SUMI~[ARY 
Using  the direct migration inhibition test,  response to measles  antigen in 
patients with systemic lupus erythematosus (SLE) was found to be decreased 
when compared with that of normal subjects. No alteration was observed in 
similar  experiments  using  parainfluenza  type  1  and  rubella  antigens.  The 
specific decrease in measles antigen effect showed no obvious correlation with 
activity of SLE or with the presence of lymphocytotoxic antibodies.  Whether 
the specificity of the decrease in  reactivity is due to  some particular relation- 
ship between the measles virus or antigen  and  SLE, or to the  possibility that 
measles reactivity is a more sensitive indicator of a generalized defect of cell- 
mediated immunity, remains unclear. 
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